News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Versant Venture Capital VI, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G/A
| Versant Venture Capital VI, L.P. reports a 19.4% stake in Century Therapeutics, Inc. |
| 01/13/2023 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 0% stake in OYSTER POINT PHARMA, INC. |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Sold 550,000 shares
@ $13.0302, valued at
$7.2M
Disposed of 364,800 shares
@ $0 |
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
SC 13G
| Versant Venture Capital VI, L.P. reports a 22.6% stake in Century Therapeutics, Inc. |
| 02/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 8.5% stake in OYSTER POINT PHARMA, INC. |
| 01/07/2022 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Disposed of 200,213 shares
@ $0
Acquired 51,556 shares
@ $0
Disposed of 51,556 shares
@ $0
Disposed of 1,261 shares
@ $0 |
|
| 12/28/2021 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Disposed of 371,004 shares
@ $0 |
|
| 12/23/2021 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Disposed of 200,213 shares
@ $0
Acquired 51,556 shares
@ $0
Disposed of 51,556 shares
@ $0
Disposed of 1,261 shares
@ $0 |
|
| 10/27/2021 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 8.6% stake in OYSTER POINT PHARMA, INC. |
| 10/20/2021 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Sold 303,614 shares
@ $14.6327, valued at
$4.4M
Sold 1,912 shares
@ $14.6327, valued at
$28k
Sold 242,943 shares
@ $15.0939, valued at
$3.7M
Sold 1,531 shares
@ $15.0939, valued at
$23.1k
|
|
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
SC 13D
| Versant Venture Capital VI, L.P. reports a 26.3% stake in Graphite Bio, Inc. |
| 07/08/2021 |
SC 13D
| Versant Venture Capital VI, L.P. reports a 15.3% stake in Monte Rosa Therapeutics, Inc. |
| 07/06/2021 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Tempest Therapeutics, Inc. |
| 07/01/2021 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Converted 12,343,727 shares
@ $0
Converted 1,527,719 shares
@ $0
Bought 180,000 shares
@ $17, valued at
$3.1M
Converted 30,019,945 preferred shares
@ $0
Converted 3,715,415 preferred shares
@ $0 |
|
| 06/30/2021 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Converted 6,515,869 shares
@ $0
Converted 1,940,043 shares
@ $0
Bought 157,895 shares
@ $19, valued at
$3M
Converted 20,004,280 convertible preferred
@ $0
Converted 3,000,000 convertible preferred
@ $0
Converted 4,150,000 convertible preferred
@ $0
Converted 2,699,328 convertible preferred
@ $0 |
|
| 06/24/2021 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Graphite Bio, Inc. |
| 06/23/2021 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
| 06/23/2021 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Converted 9,936,011 shares
@ $0
Converted 614,095 shares
@ $0
Bought 100,000 shares
@ $20, valued at
$2M
Converted 25,000,000 preferred shares
@ $0
Converted 1,545,125 preferred shares
@ $0 |
|
| 06/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/17/2021 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Century Therapeutics, Inc. |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 5.1% stake in Aligos Therapeutics, Inc. |
| 04/08/2021 |
SC 13D
| Versant Venture Capital VI, L.P. reports a 13.4% stake in LAVA THERAPEUTICS N.V. |
| 04/05/2021 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 8.6% stake in OYSTER POINT PHARMA, INC. |
|
|
|